Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0HC7.L Stock Summary
Top 10 Correlated ETFs
0HC7.L
In the News
0HC7.L Financial details
Company Rating
Neutral
Market Cap
13.11B
Income
1.57B
Revenue
9.62B
Book val./share
80.2
Cash/share
7.58
Dividend
1.6
Dividend %
1.2%
Employees
9K
Optionable
No
Shortable
Yes
Earnings
01 May 2024
P/E
4.73
Forward P/E
-
PEG
-1.14
P/S
0.01
P/B
1.59
P/C
15.31
P/FCF
0.3
Quick Ratio
0.71
Current Ratio
1.81
Debt / Equity
0.43
LT Debt / Equity
0.36
-
-
EPS (TTM)
13.34
EPS next Y
-
EPS next Q
-
EPS this Y
-41.51%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
21.62%
Revenue last 5Y
21.79%
Revenue Q/Q
1.97%
EPS Q/Q
-304.67%
-
-
-
-
SMA20
-
SMA50
5.13%
SMA100
-0.81%
Inst Own
-
Inst Trans
-
ROA
18%
ROE
36%
ROC
0.15%
Gross Margin
29%
Oper. Margin
23%
Profit Margin
34%
Payout
6%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
108.52-247.2685
52W High
-53.02%
52W Low
+7.45%
RSI
43
Rel Volume
0.39
Avg Volume
7.72K
Volume
3.05K
Perf Week
-10.15%
Perf Month
-1.87%
Perf Quarter
-17.24%
Perf Half Y
-30.88%
-
-
-
-
Beta
1.606
-
-
Volatility
5.31%, 4.58%
Prev Close
0.83%
Price
116.05
Change
-
0HC7.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 33.76 | 29.29 | 28.56 | 62.14 | 81.66 | |
Net income per share | 5.02 | 3.52 | 1.06 | 22.84 | 13.36 | |
Operating cash flow per share | 6.77 | 7.48 | 2.95 | 16.2 | 11.25 | |
Free cash flow per share | -1.25 | -0.48 | -5.23 | 5.49 | -7 | |
Cash per share | 5.77 | 6.99 | 3.77 | 12.73 | 7.56 | |
Book value per share | 36.98 | 39.96 | 48.27 | 67.77 | 79.92 | |
Tangible book value per share | 20.32 | 22.98 | 33.46 | 53.36 | 68.23 | |
Share holders equity per share | 36.98 | 39.96 | 48.27 | 67.77 | 79.92 | |
Interest debt per share | 29.13 | 34.07 | 20.91 | 28.19 | 36.36 | |
Market cap | 7.65B | 15.81B | 27.3B | 25.34B | 16.95B | |
Enterprise value | 10.22B | 18.77B | 29.42B | 27.19B | 20.37B | |
P/E ratio | 14.34 | 42.07 | 220.77 | 9.42 | 10.77 | |
Price to sales ratio | 2.13 | 5.05 | 8.2 | 3.46 | 1.76 | |
POCF ratio | 10.63 | 19.79 | 79.31 | 13.28 | 12.79 | |
PFCF ratio | -57.75 | -306.55 | -44.8 | 39.21 | -20.57 | |
P/B Ratio | 1.94 | 3.7 | 4.85 | 3.17 | 1.8 | |
PTB ratio | 1.94 | 3.7 | 4.85 | 3.17 | 1.8 | |
EV to sales | 2.85 | 6 | 8.84 | 3.71 | 2.12 | |
Enterprise value over EBITDA | 11.37 | 24.77 | 37.39 | 9.7 | 30.36 | |
EV to operating cash flow | 14.21 | 23.5 | 85.45 | 14.25 | 15.37 | |
EV to free cash flow | -77.2 | -364.04 | -48.27 | 42.08 | -24.73 | |
Earnings yield | 0.07 | 0.02 | 0 | 0.11 | 0.09 | |
Free cash flow yield | -0.02 | 0 | -0.02 | 0.03 | -0.05 | |
Debt to equity | 0.77 | 0.83 | 0.42 | 0.4 | 0.43 | |
Debt to assets | 0.31 | 0.34 | 0.21 | 0.21 | 0.22 | |
Net debt to EBITDA | 2.86 | 3.91 | 2.69 | 0.66 | 5.1 | |
Current ratio | 1.58 | 1.22 | 1.07 | 1.89 | 1.47 | |
Interest coverage | 8.25 | 5.08 | 6.26 | 17.58 | 1.28 | |
Income quality | 1.35 | 2.13 | 2.78 | 0.71 | 0.84 | |
Dividend Yield | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.29 | 0.43 | 1.44 | 0.07 | 0.12 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | |
Intangibles to total assets | 0.2 | 0.19 | 0.17 | 0.12 | 0.09 | |
Capex to operating cash flow | -1.18 | -1.06 | -2.77 | -0.66 | -1.62 | |
Capex to revenue | -0.24 | -0.27 | -0.29 | -0.17 | -0.22 | |
Capex to depreciation | -3.99 | -3.67 | -3.75 | -4.19 | -5 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0 | -0.26 | |
Graham number | 64.6 | 56.24 | 33.95 | 186.6 | 155.01 | |
ROIC | 0.08 | 0.06 | 0.05 | 0.19 | -0.01 | |
Return on tangible assets | 0.07 | 0.04 | 0.01 | 0.2 | 0.09 | |
Graham Net | -39.55 | -41.03 | -32.59 | -30.92 | -44.65 | |
Working capital | 816.11M | 404.34M | 133.65M | 2.45B | 1.66B | |
Tangible asset value | 2.16B | 2.45B | 3.9B | 6.29B | 8.04B | |
Net current asset value | -3.54B | -3.78B | -3.16B | -2.08B | -3.39B | |
Invested capital | 0.77 | 0.83 | 0.42 | 0.4 | 0.43 | |
Average receivables | 679.08M | 695.14M | 668.94M | 1.07B | 1.64B | |
Average payables | 548.33M | 528.68M | 565.6M | 1.35B | 2.07B | |
Average inventory | 734.76M | 759.61M | 781.58M | 1.44B | 2.12B | |
Days sales outstanding | 76.51 | 74.41 | 76.78 | 72.23 | 69.65 | |
Days payables outstanding | 89.92 | 82.68 | 101.97 | 176.88 | 90.56 | |
Days of inventory on hand | 120.43 | 128.36 | 127.92 | 178.95 | 93.73 | |
Receivables turnover | 4.77 | 4.91 | 4.75 | 5.05 | 5.24 | |
Payables turnover | 4.06 | 4.41 | 3.58 | 2.06 | 4.03 | |
Inventory turnover | 3.03 | 2.84 | 2.85 | 2.04 | 3.89 | |
ROE | 0.14 | 0.09 | 0.02 | 0.34 | 0.17 | |
Capex per share | -8.01 | -7.96 | -8.18 | -10.71 | -18.25 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 22.23 | 21.9 | 20.13 | 19.62 | 20.08 | |
Net income per share | 9.6 | 10.51 | 5.52 | 2.57 | -5.26 | |
Operating cash flow per share | 8.08 | 6.12 | 0.63 | 5.34 | -0.84 | |
Free cash flow per share | 4.3 | 2.59 | -3.65 | 0.7 | -6.67 | |
Cash per share | 12.71 | 13.47 | 13.58 | 13.6 | 7.58 | |
Book value per share | 67.69 | 78.18 | 83.34 | 84.03 | 80.2 | |
Tangible book value per share | 53.3 | 63.99 | 69.45 | 70.43 | 68.47 | |
Share holders equity per share | 67.69 | 78.18 | 83.34 | 84.03 | 80.2 | |
Interest debt per share | 27.15 | 27.36 | 29.4 | 30.62 | 35.17 | |
Market cap | 25.37B | 26.07B | 26.25B | 20.25B | 16.89B | |
Enterprise value | 27.22B | 27.86B | 28.32B | 22.46B | 20.31B | |
P/E ratio | 5.6 | 5.26 | 10.1 | 16.74 | -6.84 | |
Price to sales ratio | 9.68 | 10.11 | 11.08 | 8.77 | 7.17 | |
POCF ratio | 26.64 | 36.16 | 356.18 | 32.21 | -171.99 | |
PFCF ratio | 50.08 | 85.38 | -61.06 | 244.16 | -21.59 | |
P/B Ratio | 3.18 | 2.83 | 2.67 | 2.05 | 1.79 | |
PTB ratio | 3.18 | 2.83 | 2.67 | 2.05 | 1.79 | |
EV to sales | 10.39 | 10.8 | 11.95 | 9.72 | 8.62 | |
Enterprise value over EBITDA | 29.35 | 23.28 | 60.74 | -1.16K | -27.15 | |
EV to operating cash flow | 28.59 | 38.64 | 384.19 | 35.72 | -206.83 | |
EV to free cash flow | 53.74 | 91.23 | -65.86 | 270.75 | -25.97 | |
Earnings yield | 0.04 | 0.05 | 0.02 | 0.01 | -0.04 | |
Free cash flow yield | 0.02 | 0.01 | -0.02 | 0 | -0.05 | |
Debt to equity | 0.4 | 0.35 | 0.35 | 0.36 | 0.43 | |
Debt to assets | 0.21 | 0.18 | 0.18 | 0.19 | 0.22 | |
Net debt to EBITDA | 2 | 1.49 | 4.43 | -114.17 | -4.57 | |
Current ratio | 1.89 | 1.9 | 1.74 | 1.81 | 1.47 | |
Interest coverage | 35.11 | 41.34 | 14.59 | -4.25 | -26 | |
Income quality | 0.84 | 0.58 | 0.11 | 2.08 | 0.16 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.04 | 0.04 | 0.07 | 0.16 | -0.08 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Intangibles to total assets | 0.12 | 0.11 | 0.1 | 0.1 | 0.09 | |
Capex to operating cash flow | -0.47 | -0.58 | -6.83 | -0.87 | 6.96 | |
Capex to revenue | -0.17 | -0.16 | -0.21 | -0.24 | -0.29 | |
Capex to depreciation | -5.21 | -4.66 | -5.41 | -5.18 | -4.69 | |
Stock based compensation to revenue | 0.01 | -0.07 | -0.08 | -0.09 | -0.12 | |
Graham number | 120.94 | 135.97 | 101.74 | 69.69 | 97.46 | |
ROIC | 0.07 | 0.07 | 0.02 | -0.01 | -0.07 | |
Return on tangible assets | 0.08 | 0.08 | 0.04 | 0.02 | -0.04 | |
Graham Net | -30.88 | -31.23 | -36.21 | -35.12 | -44.81 | |
Working capital | 2.45B | 3.15B | 3.16B | 3.18B | 1.66B | |
Tangible asset value | 6.29B | 7.54B | 8.18B | 8.3B | 8.04B | |
Net current asset value | -2.08B | -1.45B | -1.57B | -1.6B | -3.39B | |
Invested capital | 0.4 | 0.35 | 0.35 | 0.36 | 0.43 | |
Average receivables | 1.31B | 1.56B | 1.72B | 1.74B | 1.77B | |
Average payables | 1.85B | 2.41B | 2.91B | 2.83B | 2.35B | |
Average inventory | 1.85B | 2.63B | 3.42B | 3.53B | 2.78B | |
Days sales outstanding | 49.74 | 58.06 | 67.25 | 66.52 | 70.1 | |
Days payables outstanding | 114.77 | 191.02 | 151.64 | 104.15 | 61.68 | |
Days of inventory on hand | 116.11 | 219.26 | 181.75 | 135.99 | 63.84 | |
Receivables turnover | 1.81 | 1.55 | 1.34 | 1.35 | 1.28 | |
Payables turnover | 0.78 | 0.47 | 0.59 | 0.86 | 1.46 | |
Inventory turnover | 0.78 | 0.41 | 0.5 | 0.66 | 1.41 | |
ROE | 0.14 | 0.13 | 0.07 | 0.03 | -0.07 | |
Capex per share | -3.78 | -3.53 | -4.28 | -4.63 | -5.83 |
0HC7.L Frequently Asked Questions
What is Albemarle Corporation stock symbol ?
Albemarle Corporation is a US stock , located in Charlotte of Nc and trading under the symbol 0HC7.L
What is Albemarle Corporation stock quote today ?
Albemarle Corporation stock price is $116.05 today.
Is Albemarle Corporation stock public?
Yes, Albemarle Corporation is a publicly traded company.